Surveillance for Low and Low-Intermediate Risk Non-muscle Invasive Bladder Cancer: A Pilot Study
A research study of 2 different approaches taken to monitoring patients with bladder cancer. In the United States, we generally follow patients by looking into their bladder every 3 months for the first year following diagnosis. On the other hand, in Europe, a less frequent approach is used (once at 3 months and again at 12 months). We believe that these approaches would not have any untoward consequences for patients, such as disease progression, but this has not been proven. This is a pilot study that aims to compare these 2 different strategies for monitoring patients with bladder cancer. We are capturing information about patient satisfaction and cost and differences in cancer relapse rates.